Skip to content

The IM ABLE Study: A Study of Warriors & Veterans Following Neuromusculoskeletal Injury of the Lower Limb

The IM ABLE Study: A Cross-Sector, Multisite Initiative to Advance Care for Warriors and Veterans Following Neuromusculoskeletal Injury of the Lower Limb

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03107728
Enrollment
120
Registered
2017-04-11
Start date
2018-02-22
Completion date
2019-09-30
Last updated
2019-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Braces, Limb Salvage, Lower Extremity

Keywords

orthotics, high-energy lower extremity trauma, physical therapy, bracing, functional performance, performance assessment

Brief summary

The purpose of the IM ABLE(Injuries Managed with Advanced Bracing for Lower Extremities) study is to determine if advanced (ADV) ankle foot orthoses (AFOs) will enable users to achieve greater levels of physical and self-reported function compared with conventional (CONV) AFOs for those ambulating at or above the independent community level of ambulation.

Detailed description

There were approximately 20,000 extremity trauma cases associated with the wars in Iraq and Afghanistan. Many of these individuals have experienced multiple limb-sparing surgeries and orthotic utilization. Many continue functioning with use of their orthosis while others may seek delayed amputation. It is unclear if limb salvage or amputation is more advantageous functionally or preferred following lower extremity(LE) trauma. The IDEO (Intrepid Dynamic Exoskeletal Orthosis) was developed to assist in maintaining high functional performance in patients who have experienced high energy lower extremity trauma (HELET) and limb salvage surgeries primarily effecting the LE below the level of the knee joint. The IDEO represents one advanced orthotic option for a traumatized and surgically spared limb however there are other advanced orthotic options. Problematically, few studies have reported outcomes associated with these devices. In the few studies available, sample sizes are small which greatly reduces generalizability of study findings. The purpose of the IM ABLE study is to determine if advanced (ADV) ankle foot orthoses (AFOs) will enable users to achieve greater levels of physical and self-reported function compared with conventional (CONV) AFOs for those ambulating at or above the independent community level of ambulation.

Interventions

DEVICEAdvanced orthotic brace

Participants will use an advanced exoskeletal orthosis.

DEVICEConventional orthotic brace

Participants will use the standard of care orthosis

Sponsors

James A. Haley Veterans Administration Hospital
CollaboratorFED
VA New York Harbor Healthcare System
CollaboratorFED
Hanger Clinic: Prosthetics & Orthotics
CollaboratorOTHER
University of South Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Lower extremity injury of any etiology requiring use of an AFO 2. Male or Female, of any ethnicity 3. 18-65 yrs of age 4. 100-275 lbs 5. ≥ 1 yr. of orthotic experience

Exclusion criteria

1. Body weight \<100 or \>275 lbs 2. Does not speak English or Spanish 3. Known cognitive impairment (i.e. Diagnoses such as Traumatic Brain Injury, Dementia)

Design outcomes

Primary

MeasureTime frameDescription
Change in MobilityMobility will be assessed at Week 2 and Week 4Mobility will be assessed with the Timed Up & Go test. subjects are timed while they rise from a chair, walk 3m, turn around, return to the chair and sit down again. Patients are usually permitted to use a walking aid, but not to use physical assistance.
Change in Ambulatory FunctionAmbulatory Function will be assessed at week 2 and week 4.The 2 Minute Walk Test will be used to assess ambulatory function

Secondary

MeasureTime frameDescription
Perceived FunctionAt week 2 and week 4Perceived Function will be assessed via the EQ-5D (EuroQol 5D), a five item ordinally scaled patient self-report.
PainAt week 2 and week 4Pain rating scale 0-10
Safety will be measured with the Activities Balance Confidence ScaleAt week 2 and week 4Safety will be measured with the Activities Balance Confidence Scale, a 16 item self-report measure of perceived balance confidence

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026